Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease
Table 1
Clinical characteristics, blood count, and biochemical characteristics of the control group and PAD patients.
Control ()
PAD ()
value
BMI (kg/m2)
24 (22.5–25.3)
25 (22.5–28)
0.021
Diabetes (%)
—
64.1
<0.001
Hypertension (%)
—
69.2
<0.001
Dyslipidemia
—
37.9
<0.001
Red blood cells, ×1012/l
4.9 (4.4–5.2)
4.16 (3.57–4.66)
<0.001
Hemoglobin, mmol/l
8.94 (8.32–9.43)
13.30 (11.50–14.90)
0.001
Leukocytes, ×109/l
6.8 (5.4–8.2)
8.17 (6.50–10.22)
0.003
Platelets, ×109/l
233 (205–273)
253 (200–329)
ns
Total cholesterol, mmol/l
4.85 (4.40–5.85)
3.90 (3.31–4.94)
<0.001
HDL cholesterol, mmol/l
1.34 (1.14–1.61)
0.96 (0.78–1.19)
<0.001
LDL cholesterol, mmol/l
2.82 (2.40–3.86)
2.26 (1.77–2.79)
<0.001
Triglycerides, mmol/l
0.90 (0.70–1.38)
1.99 (1.40–3.08)
<0.001
Glucose, mmol/l
4.70 (4.37–4.92)
5.61 (4.60–6.88)
<0.001
ALT, U/l
20 (13.5–24.9)
21.5 (15–34.8)
ns
AST, U/l
20 (17.7–24)
21 (16–32)
ns
BMI: Body mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ns: not significant. Nonparametric variables are shown as medians, and IQR are in parentheses. Qualitative variables are expressed as percentage of total participants.
